AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading ABBV News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
MRKMerck & Co., Inc.
3.65%62.530.6%$770.31m
PFEPfizer Inc.
0.21%31.770.7%$682.69m
JNJJohnson & Johnson
-0.04%114.150.7%$598.50m
BMYBristol-Myers Squibb Company
-11.29%49.230.7%$554.17m
ABBVAbbVie, Inc.
-0.39%61.142.1%$415.97m
LLYEli Lilly and Company
-0.05%76.801.0%$325.59m
NVSNovartis AG Sponsored ADR
0.31%70.650.2%$244.73m
AZNAstraZeneca PLC Sponsored ADR
-3.01%27.071.0%$157.50m
GSKGlaxoSmithKline plc Sponsored ADR
-0.08%38.720.2%$127.25m
SNYSanofi Sponsored ADR
0.55%40.390.1%$83.32m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.25%35.540.2%$75.96m
LCILannett Company, Inc.
0.65%19.3330.2%$21.40m
SCMPSucampo Pharmaceuticals, Inc. Class A
-0.44%11.4015.0%$13.03m
AKTXAkari Therapeutics Plc Sponsored ADR
-6.63%7.470.1%$0.02m
EPIXESSA Pharma Inc
0.00%2.020.0%$0.01m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.